Form 4: TD SYNNEX Executive Sells Shares After Option Exercise
Insider Transaction Report
Dennis Polk, a Director and Hyve Solutions Executive at TD SYNNEX, exercised stock options and subsequently sold a portion of the acquired common stock.
Summary
- Dennis Polk, a Director and Hyve Solutions Executive, engaged in multiple transactions involving TD SYNNEX common stock on October 9, 2025.
- Exercised employee stock options to acquire 14,320 shares of common stock at an exercise price of $90.52 per share.
- Exercised additional stock options to acquire 3,180 shares of common stock at an exercise price of $106.35 per share.
- Sold 1,493 shares of common stock at a weighted average price of $155.68 per share.
- Sold 14,693 shares of common stock at a weighted average price of $156.54 per share.
- Sold 1,314 shares of common stock at a weighted average price of $157.01 per share.
- Following these transactions, direct beneficial ownership stands at 31,117 shares of common stock.
- Indirect beneficial ownership, held by a Trust, remains at 81,660 shares of common stock.
- A total of 5,982 stock options remain beneficially owned directly.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive for the insider due to profitable option exercises, but neutral for the company as insider selling, while common, can sometimes be viewed with caution. It does not inherently signal a negative outlook for the company.
Positives
- The executive realized a significant profit by exercising stock options at lower prices ($90.52 and $106.35) and selling the shares at substantially higher market prices (ranging from $155.68 to $157.01).
Negatives
- The sale of a substantial number of shares by a Director and Executive, totaling 17,500 shares, could be perceived by some investors as a reduction in insider exposure, although it is a common practice for personal financial planning and diversification.
Future Outlook
This Form 4 filing reports past insider transactions and does not contain any forward-looking statements or guidance regarding the company's future outlook.
Industry Context
This filing details an individual insider transaction and does not provide broader industry context or relate to overall industry trends or competitor performance.
Stakeholder Impact
- Shareholders: May interpret the insider's sale of shares as a signal, though such transactions are often for personal financial management and diversification rather than a reflection of company performance.
Key Dates
| Date | Description |
|---|---|
| 10/07/2020 | Vesting start date for 14,320 employee stock options. |
| 10/09/2025 | Date of all reported stock option exercises and common stock sales. |
| 10/10/2025 | Date the Form 4 filing was signed. |
| 01/20/2031 | Expiration date for 14,320 employee stock options. |
| 01/19/2032 | Expiration date for 3,180 stock options. |
Recommendation
holdThe filing details an insider's exercise of stock options and subsequent sale of a portion of the acquired shares. While the insider profited from the transactions, the sale of shares by a Director and Executive could be viewed with caution by some investors. However, such transactions are common for personal financial planning and diversification, and do not inherently signal a negative outlook for the company. A 'hold' recommendation is appropriate as this single transaction does not provide sufficient information to alter a fundamental investment thesis for TD SYNNEX, but it warrants monitoring alongside other company developments.
Keywords
TD SYNNEX, SNX, insider trading, stock options, Form 4, Dennis Polk, share sale, equity transactions
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.